14,188 Shares in CVS Health Corporation $CVS Purchased by Focus Partners Advisor Solutions LLC

Key Points

• Focus Partners Advisor Solutions LLC acquired 14,188 shares of CVS Health Corporation, totaling around $961,000 in value, marking a significant investment in the company.
• CVS Health reported an earnings per share (EPS) of $1.81 for the recent quarter, exceeding analysts' expectations of $1.46 and earning $98.92 billion in revenue.
• The company is offering a quarterly dividend of $0.665 per share, representing an annual yield of 3.6% and a payout ratio of 74.30%.

Focus Partners Advisor Solutions LLC acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,188 shares of the pharmacy operator's stock, valued at approximately $961,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Essex Financial Services Inc. raised its holdings in CVS Health by 0.8% during the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after buying an additional 166 shares during the period. Hemington Wealth Management grew its stake in CVS Health by 33.7% during the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock valued at $46,000 after acquiring an additional 172 shares in the last quarter. McIlrath & Eck LLC grew its stake in shares of CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after buying an additional 174 shares in the last quarter. Sumitomo Life Insurance Co. grew its stake in shares of CVS Health by 1.0% in the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock valued at $1,159,000 after buying an additional 174 shares in the last quarter. Finally, Koshinski Asset Management Inc. grew its stake in shares of CVS Health by 3.7% in the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after buying an additional 178 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of NYSE CVS opened at $73.34 on Thursday. The business has a fifty day simple moving average of $66.39 and a 200 day simple moving average of $65.89. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $93.01 billion, a price-to-earnings ratio of 20.48, a PEG ratio of 0.81 and a beta of 0.62. CVS Health Corporation has a one year low of $43.56 and a one year high of $74.53.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health's revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.6%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio is currently 74.30%.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.22% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CVS has been the subject of a number of recent analyst reports. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $78.00 target price on shares of CVS Health in a research report on Tuesday, August 26th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, August 4th. Jefferies Financial Group upped their target price on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Robert W. Baird upgraded CVS Health from a "neutral" rating to an "outperform" rating and upped their price target for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. Finally, Truist Financial upped their price target on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $77.56.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.